Paul Averback

Chief Executive Officer at NYMOX PHARMACEUTICAL CORPORATION

Net worth: 20 M $ as of 29/09/2023

73 year

100 connections

Distribution Services

Health Technology

Consumer Services

Active connections

Name	Gender	Age	Linked companies	Collaboration
David S. Morse	M	67	NYMOX PHARMACEUTICAL CORPORATION	18 years
James G. Robinson	M	88	NYMOX PHARMACEUTICAL CORPORATION	9 years
Christopher Riley	M	-	NYMOX PHARMACEUTICAL CORPORATION	1 years
Patrick Doody	M	-	NYMOX PHARMACEUTICAL CORPORATION	1 years
Russell I. Thomson	M	-	NYMOX PHARMACEUTICAL CORPORATION	4 years
Suresh Kalbag	M	-	NYMOX PHARMACEUTICAL CORPORATION	-

Connections Chart

Multi-company connection

Former connections

Name	Gender	Age	Linked companies	Collaboration
Randall Lanham	M	59	NYMOX PHARMACEUTICAL CORPORATION	17 years
André Monette	M	66	NYMOX PHARMACEUTICAL CORPORATION	1 years
Jack Gemmell	M	72	NYMOX PHARMACEUTICAL CORPORATION	-
M. Cutler	M	66	NYMOX PHARMACEUTICAL CORPORATION	8 years
Mike Gunn	M	-	University of Cambridge	7 years
Erik Danielsen	M	60	NYMOX PHARMACEUTICAL CORPORATION	-
Brian Doyle	M	69	NYMOX PHARMACEUTICAL CORPORATION	11 years
Gareth Beynon	M	-	University of Cambridge	6 years
Roger Guy	M	73	NYMOX PHARMACEUTICAL CORPORATION	8 years
Bahman Yamini	M	-	University of Cambridge	5 years
Chong Kiat Lim	M	68	University of Cambridge	7 years
Belita S. Ong	F	-	University of Cambridge	4 years
Paul F. McDonald	M	98	NYMOX PHARMACEUTICAL CORPORATION	9 years
Steven Troop	M	-	University of Cambridge	4 years
Joanna Mary Gordon Perry	F	67	University of Cambridge	3 years
James Edward Smith	M	71	University of Cambridge	3 years
Alistair Eric MacCallum Laband	M	73	University of Cambridge	3 years
Mike Schraer	M	-	University of Cambridge	2 years
Andrew Unitt	M	66	University of Cambridge	4 years
Peter Highfield	M	-	University of Cambridge	4 years
David Harrison	M	-	University of Cambridge	1 years
Nigel Smethers	M	-	University of Cambridge	4 years
Richard Burnett-Hall	M	-	University of Cambridge	1 years
Geoffrey Hale	M	-	University of Cambridge	3 years
Steven E. Hyman	M	71	University of Cambridge	1 years
Anne Fabienne Weitsch	M	-	University of Cambridge	3 years
Graham May	M	65	University of Cambridge	3 years
William Gilfillan Lamarque	M	70	University of Cambridge	4 years
Paul Hanworth	M	-	University of Cambridge	3 years
Paul Young	M	68	University of Cambridge	4 years
Tong Boon Quek	M	68	University of Cambridge	4 years
Takeshi Ito	M	80	University of Cambridge	1 years
Nai Pong Wai	M	70	University of Cambridge	4 years
Raymond Liu	M	67	University of Cambridge	4 years
John Buchanan	M	72	University of Cambridge	4 years
Thomas Michael Taylor	M	68	University of Cambridge	4 years
Archibald Cox	M	-	University of Cambridge	-
Nigel Keith Anthony Standish Vaz	M	67	University of Cambridge	4 years
Mark Wainwright Todd	M	69	University of Cambridge	4 years
Colin David Beckett	M	-	University of Cambridge	1 years
Geoffrey Hale	M	-	University of Cambridge	3 years
James S. Wilson	M	72	University of Cambridge	1 years
Robert Gresham Gray	M	70	University of Cambridge	4 years
Michael Norland Higgin	M	75	University of Cambridge	4 years
Tony H. J. Quick	M	68	University of Cambridge	3 years
Steven C. Schroer	M	-	University of Cambridge	3 years
Martin Andrew McInroy	M	69	University of Cambridge	3 years
Michael Owen	M	73	University of Cambridge	3 years
Alan Colman	M	75	University of Cambridge	3 years
Philip Hanson	M	67	University of Cambridge	4 years
Nicholas French	M	-	University of Cambridge	1 years
Alastair K. Livesey	M	67	University of Cambridge	4 years
Peter Jackson	M	62	University of Cambridge	4 years
Lim Andy	M	66	University of Cambridge	4 years
Walter P. von Wartburg	M	84	NYMOX PHARMACEUTICAL CORPORATION	-
Frank Christian Wignall	M	68	University of Cambridge	4 years
Mehran Nakhjavani	M	-	University of Cambridge	3 years
Hans P. Black	M	71	NYMOX PHARMACEUTICAL CORPORATION	-
James Mcmoran Wilson	M	72	University of Cambridge	1 years
Timothy Norman Wallach	M	-	University of Cambridge	4 years
Michael Munzar	M	-	NYMOX PHARMACEUTICAL CORPORATION	8 years
Roy M. Wolvin	M	69	NYMOX PHARMACEUTICAL CORPORATION	19 years
Michael R. Sonnenreich	M	85	NYMOX PHARMACEUTICAL CORPORATION	-
Hugh Nineham	M	-	University of Cambridge	3 years
James Barstow	M	74	University of Cambridge	4 years
David Turnbull	M	69	University of Cambridge	4 years
Andrew Hopper	M	71	University of Cambridge	3 years
Dominic Casserley	M	67	University of Cambridge	4 years
David Dew	M	69	University of Cambridge	4 years
Charles Baker	M	66	University of Cambridge	4 years
David Sidwell	M	71	University of Cambridge	4 years
Francis McCormick	M	73	University of Cambridge	3 years
Reyaz A. Ahmad	M	-	University of Cambridge	5 years
Robert J. West	M	-	University of Cambridge	4 years
Stewart W. Robinson	M	-	University of Cambridge	4 years
Syn Pau Lew	M	70	University of Cambridge	4 years
Adam C. Baker	M	-	University of Cambridge	4 years
Peter J. Duffett-Smith	M	-	University of Cambridge	3 years
Thomas Martin Connelly	M	71	University of Cambridge	3 years
Andrew Galazka	M	69	University of Cambridge	3 years
Christopher Batterham	M	68	University of Cambridge	4 years
Jonathan E. Clegg	M	-	University of Cambridge	4 years
Peter Bazalgette	M	71	University of Cambridge	4 years
Celine Dupuis	M	65	NYMOX PHARMACEUTICAL CORPORATION	-
Mark Christopher Greaves	M	67	University of Cambridge	4 years
Roger G. Byford	M	-	University of Cambridge	3 years
Rajesh Viren Shah	M	72	University of Cambridge	3 years
Alan Hastings Drummond	M	-	University of Cambridge	3 years
Mark Staples	M	-	NYMOX PHARMACEUTICAL CORPORATION	-
Chris Hills	M	-	University of Cambridge	4 years
Gordon Cudmore	M	-	University of Cambridge	3 years
Richard Leslie Martin Wohanka	M	71	University of Cambridge	4 years
Desmond Radlein	M	74	University of Cambridge	3 years
Richard Greer	M	-	University of Cambridge	3 years

Statistics

Country	Connections	% of total
United Kingdom	79	79.00%
Bahamas	21	21.00%

Age of Connections

Active

Past

Male

Female

Members of the board

Executives

Origin of connections